- Home
- / Novo Integrated Sciences
Novo Integrated Sciences
Stock Price
$0.2
2024-10-29
Market Capitalization
$3.9 M
2024-10-29
Revenue
$13.3 M
FY, 2024
Novo Integrated Sciences Summary
Company Summary
- Overview
- Novo Integrated Sciences is a provider of healthcare solutions. It offers physiotherapy, chiropractic, massage therapy, chiropody, eldercare, diagnosis, treatment, pain management, rehabilitation, and other services.
- Type
- Public
- Status
- Active
- Founded
- 2000
- HQ
- Bellevue, WA, US | view all locations
- Website
- https://novointegrated.com
- Cybersecurity rating
Table of Contents
Key People
Robert Mattacchione, Chairman, Board of Directors & CEO
Michael Gaynor, Chief Operating Officer, Novo Healthnet Limited
LocationsView all
2 locations detected
Bellevue, WA HQ
United States
11120 NE 2nd St #100
Las Vegas, NV
United States
6725 Via Austi Pkwy #300
Novo Integrated Sciences Financials
Summary Financials
- Revenue (FY, 2024)
- $13.3M
- Gross profit (FY, 2024)
- $5.7M
- Net income (FY, 2024)
- ($16.1M)
- Cash (FY, 2024)
- $844.6K
- EBIT (FY, 2024)
- ($10.1M)
- Enterprise value
- $5.9M